The NIH ENDGAME Consortium
نویسنده
چکیده
The effect of the 2-nitroimidazole Ro 03-8799 (8799) on the activity of 11 chemotherapeutic agents against the anaplastic MT tumour in mice has been determined by soft agar cloning. The 8799, whilst producing little cytotoxicity by itself, potentiated the cytotoxic actions of the alkylating agents melphalan and cyclophosphamide, and the nitrosoureas BCNU, CCNU and MeCCNU. This potentiation was influenced by the time interval between the administration of 8799 and the chemotherapeutic agents, and also by the site of tumour implantation. However, 8799 did not potentiate the cytotoxicities of the compounds CBDCA, cisplatin, adriamycin, vincristine, 5-fluorouracil and bleomycin. A review is included of the reported in vivo effects of nitroimidazoles on the chemotherapeutic agents investigated here.
منابع مشابه
The Nih Pain Consortium 3 Rd Annual Symposium on Advances in Pain Research Natcher Auditorium/nih Campus
Dr. Grady spoke on behalf of the NIH Pain Consortium, and noted that she was representing not only herself but also Dr. Story Landis, Director of the National Institute for Neurological Disorders and Stroke, Dr. Larry Tabak, Director of the National Institute of Dental and Craniofacial Research, and all of the 20 NIH Institutes and Centers participating in the Consortium. She said that this yea...
متن کاملHighlights of the Nih Pain Consortium 4 Th Annual Symposium on Advances in Pain Research Nih Natcher Conference Center Opening Remarks and Introduction of New Co-leaders Comments from New Co-leaders
Dr. Grady reviewed the history and goals of the Pain Consortium, which serves as the coordinating group for the 20 NIH Institutes and Centers (ICs) that fund pain research. These Institutes and Centers are investing a total of $279 million in pain research this year. Dr. Grady discussed two recent funding opportunities for pain research available through the American Recovery and Reinvestment A...
متن کاملS3 Table
study design, analysis and interpretation The following table summarizes several key concepts relating to sample preparation and library construction that may influence analysis and interpretation of RNA-seq data. Several initiatives are underway to develop standards and best practices that cover many of these concepts. These include: the Sequencing Quality Control (SEQC) consortium [2], the En...
متن کاملEvaluating efforts to diversify the biomedical workforce: the role and function of the Coordination and Evaluation Center of the Diversity Program Consortium
Background The National Institutes of Health (NIH)-funded Diversity Program Consortium (DPC) includes a Coordination and Evaluation Center (CEC) to conduct a longitudinal evaluation of the two signature, national NIH initiatives - the Building Infrastructure Leading to Diversity (BUILD) and the National Research Mentoring Network (NRMN) programs - designed to promote diversity in the NIH-funded...
متن کاملEthical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experience.
In 2007, the National Human Genome Research Institute (NHGRI) established the Electronic MEdical Records and GEnomics (eMERGE) Consortium (www.gwas.net) to develop, disseminate, and apply approaches to research that combine DNA biorepositories with electronic medical record (EMR) systems for large-scale, high-throughput genetic research. One of the major ethical and administrative challenges fo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 114 شماره
صفحات -
تاریخ انتشار 2006